Related Experiment Video
Updated: Jun 16, 2026

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
Polypodium leucotomos Gummy Supplementation in the Pediatric Population: A Retrospective Series Demonstrating Safety
Cindy Hakim1, Alina Galaria2, Aamir Hussain3
1University of Michigan Medical School, Ann Arbor, Michigan, USA.
Abstract:
Polypodium leucotomos extract (PLE) has been widely studied for its antioxidant, photoprotective, and anti-inflammatory properties, but limited data exist regarding its use in children. This retrospective study evaluated the safety of a gummy-based PLE supplement (Inner Glow Sol Defense, 280 mg) in 77 pediatric patients across three dermatology clinics. Patients took the supplement for a median of 4 months with no documented adverse effects, including in cases of prolonged use and accidental overdose. These findings support the safety of PLE supplementation in the pediatric population.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug Dosing: Infants and Children
Prevention of Further Absorption of Poison